Genetic Markers of Insulin Resistance and Atherosclerosis in Type 2 Diabetes Mellitus Patients with Coronary Artery Disease

Type 2 diabetes mellitus (T2DM) is characterized by impaired insulin secretion on a background of insulin resistance (IR). IR and T2DM are associated with atherosclerotic coronary artery disease (CAD). The mechanisms of IR and atherosclerosis are known to share similar genetic and environmental roots. Endothelial dysfunction (ED) detected at the earliest stages of IR might be the origin of atherosclerosis progression. ED influences the secretion of pro-inflammatory cytokines and their encoding genes. The genes and their single nucleotide polymorphisms (SNPs) act as potential genetic markers of IR and atherosclerosis. This review focuses on the link between IR, T2DM, atherosclerosis, CAD, and the potential genetic markers CHI3L1, CD36, LEPR, RETN, IL-18, RBP-4, and RARRES2 genes.

Medienart:

E-Artikel

Erscheinungsjahr:

2023

Erschienen:

2023

Enthalten in:

Zur Gesamtaufnahme - volume:13

Enthalten in:

Metabolites - 13(2023), 3 vom: 14. März

Sprache:

Englisch

Beteiligte Personen:

Perumalsamy, Sangeetha [VerfasserIn]
Huri, Hasniza Zaman [VerfasserIn]
Abdullah, Bashar Mudhaffar [VerfasserIn]
Mazlan, Othman [VerfasserIn]
Wan Ahmad, Wan Azman [VerfasserIn]
Vethakkan, Shireene Ratna D B [VerfasserIn]

Links:

Volltext

Themen:

Atherosclerosis
Coronary artery disease
Endothelial dysfunction
Genetic markers
Insulin resistance
Journal Article
Review
Single nucleotide polymorphisms
Type 2 diabetes mellitus

Anmerkungen:

Date Revised 31.03.2023

published: Electronic

Citation Status PubMed-not-MEDLINE

doi:

10.3390/metabo13030427

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM354898302